Objective To evaluate the effectiveness of oral administration of mifepristone combined with laparoscopy for tubal pregnancy.Methods A total of 64 patients were freely divided into two groups: the Study Group(n=32) and the Control Group(n=32).The Study Group was given 150 mg mifepristone 24 h before laparoscopy and the Control Group was not given mifepristone.Results The intraoperative hemorrhage volume and the operation time were 232.0?170.6 ml and 35.2?5.8 min in the Study Group and 391.9?239.2 ml and 40.8?6.1 min in the Control Group,respectively,with significant differences between the two groups((P

Objective To evaluate hysteroscopy,transvaginal sonography and pathologic examination in the diagnosis of abnormal uterine bleeding(AUB).Methods 64 patients that preliminary diagnosesed of AUB from October 2003 to June 2005 were retrospectively analyzed.Results 22 cases were reported by transvaginal sonography as abnormal endometrium.As to hysteroscopy,62 cases were diagnosed.63 cases were reported abnormal by pathologic examination.Conclusion The hysteroscopy combined with Transvaginal sonography,tissue pathological examination of localizational endometrial biopsy or endometrial curettage can improve the accuracy of diagnosis of endometrial disease.

Objective To assess the effect of magnetic resonance imaging (MRI) on preoperative staging of endometrial carcinoma and depth of myometrial invasion. Methods Fifty-six patients with endometrial carcinoma were underwent conventional and contrast-enhanced MR scan. The results of pathology , MRI examinations of preoperative staging and depth of myometrial invasion were assessed and compared. Results The accurate rate of MRI diagnosis in preoperative staging diagnosis was 82.1% (46/56) and the consistency check as Kappa was 0.771 (P < 0.001). Conclusions MRI may be a good diagnostic tool with high sensitivity and specificity for assessing myometrial invasion and detecting tumour extension and should be considered as a routine part of the preoperative assessment in all patients with endometrial carcinoma.